Followers | 520 |
Posts | 40228 |
Boards Moderated | 21 |
Alias Born | 09/16/2007 |
Monday, May 23, 2011 5:48:04 PM
Datatrak Intl (QX) (USOTC:DATA)
Intraday Stock Chart
Today : Monday 23 May 2011
Click Here for more Datatrak Intl (QX) Charts.
DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the Company's selection as a 2011 Crain's Leading EDGE award winner for the second consecutive year.
"Being once again recognized as an EDGE award recipient emphasizes the hard work and dedication DATATRAK and its employees have to bringing a quality product to the clinical trials industry," said Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "Our DATATRAK ONE™ product suite provides our customers with a safer, unified approach to accelerating their drug/device to the market."
About Crain's Leading EDGE Awards
The Entrepreneurs EDGE is a resource for CEOs and their Leadership Teams to share best practices, help solve challenging issues, and take best advantage of their biggest opportunities. EDGE is a 501 (c) (3) non-profit founded in 2005 to enhance economic development in Northeast Ohio. Please see http://www.edgef.org for additional information.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s quarterly report filed with the OTCQX Market on May 18, 2011 announcing its results for the three-month period ending March 31, 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM